American Society for Enhanced Recovery and Perioperative Quality Initiative joint consensus statement on patient-reported outcomes in an enhanced recovery …

RE Abola, E Bennett-Guerrero, ML Kent… - Anesthesia & …, 2018 - journals.lww.com
Patient-reported outcomes (PROs) are measures of health status that come directly from the
patient. PROs are an underutilized tool in the perioperative setting. Enhanced recovery …

PROMIS®-29 v2.0 profile physical and mental health summary scores

RD Hays, KL Spritzer, BD Schalet, D Cella - Quality of life Research, 2018 - Springer
Abstract Purpose The PROMIS-29 v2. 0 profile assesses pain intensity using a single 0–10
numeric rating item and seven health domains (physical function, fatigue, pain interference …

[HTML][HTML] Evolution of patient-reported outcomes and their role in multiple sclerosis clinical trials

CJ Nowinski, DM Miller, D Cella - Neurotherapeutics, 2017 - Elsevier
Patient-reported outcomes (PROs) are playing an increasing role in multiple sclerosis (MS)
research and practice, and are essential for understanding the effects that MS and MS …

Estimation of a Preference-Based Summary Score for the Patient-Reported Outcomes Measurement Information System: The PROMIS®-Preference (PROPr) Scoring …

B Dewitt, D Feeny, B Fischhoff, D Cella… - Medical Decision …, 2018 - journals.sagepub.com
Background. Health-related quality of life (HRQL) preference-based scores are used to
assess the health of populations and patients and for cost-effectiveness analyses. The …

Evaluating the PROMIS-29 v2. 0 for use among older adults with multiple chronic conditions

AJ Rose, E Bayliss, W Huang, L Baseman… - Quality of Life …, 2018 - Springer
Abstract Purpose The Patient-Reported Outcomes Measurement Information System 29-item
profile (PROMIS-29 v2. 0), which measures health-related quality of life (HRQoL), has had …

Rituximab versus azathioprine as therapy for maintenance of remission for anti-neutrophil cytoplasm antibody-associated vasculitis (RITAZAREM): study protocol for a …

S Gopaluni, RM Smith, M Lewin, CA McAlear… - Trials, 2017 - Springer
Background Rituximab is effective as therapy for induction of remission in anti-neutrophil
cytoplasmic antibody (ANCA)-associated vasculitis (AAV). However, the effect of rituximab is …

Evaluation of PROMIS Preference Scoring System (PROPr) in patients undergoing hemodialysis or kidney transplant

J Zhang, B Dewitt, E Tang, D Breitner… - Clinical Journal of the …, 2021 - journals.lww.com
Results The mean (SD) age of the 524 participants was 57 (17) years, 58% were male, and
45% were White. Median (interquartile range) score was 0.39 (0.24–0.58) for PROPr, 0.69 …

[HTML][HTML] Value-based sleep and breathing: health economic aspects of obstructive sleep apnea

EM Wickwire - Faculty reviews, 2021 - ncbi.nlm.nih.gov
Obstructive sleep apnea (OSA) is a common and costly medical condition. Untreated OSA is
associated with numerous and well-documented adverse health consequences including …

Cross-sectional validation of the PROMIS-Preference scoring system

J Hanmer, B Dewitt, L Yu, J Tsevat, M Roberts… - PloS one, 2018 - journals.plos.org
Objectives The PROMIS-Preference (PROPr) score is a recently developed summary score
for the Patient-Reported Outcomes Measurement Information System (PROMIS). PROPr is a …

Selection of key health domains from PROMIS® for a generic preference-based scoring system

J Hanmer, D Cella, D Feeny, B Fischhoff, RD Hays… - Quality of Life …, 2017 - Springer
Purpose We sought to select a parsimonious subset of domains from the patient-reported
outcomes measurement information system (PROMIS®) that could be used for preference …